USANA Health Sciences, Inc. (NYSE:USNA) major shareholder Global Ltd Gull sold 43,292 shares of the stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $65.25, for a total value of $2,824,803.00. Following the completion of the transaction, the insider now owns 12,053,403 shares in the company, valued at $786,484,545.75. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Major shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Global Ltd Gull also recently made the following trade(s):

  • On Thursday, October 26th, Global Ltd Gull sold 60,871 shares of USANA Health Sciences stock. The shares were sold at an average price of $67.39, for a total value of $4,102,096.69.
  • On Monday, October 30th, Global Ltd Gull sold 93,443 shares of USANA Health Sciences stock. The shares were sold at an average price of $67.08, for a total value of $6,268,156.44.
  • On Thursday, September 14th, Global Ltd Gull sold 79,294 shares of USANA Health Sciences stock. The shares were sold at an average price of $57.61, for a total value of $4,568,127.34.
  • On Tuesday, September 5th, Global Ltd Gull sold 40,000 shares of USANA Health Sciences stock. The shares were sold at an average price of $58.41, for a total value of $2,336,400.00.

USANA Health Sciences (NYSE:USNA) last posted its earnings results on Tuesday, October 24th. The company reported $1.02 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.11. The firm had revenue of $261.77 million for the quarter, compared to analysts’ expectations of $259.52 million. USANA Health Sciences had a net margin of 8.79% and a return on equity of 26.54%. The company’s revenue was up 3.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.40 earnings per share.

USANA Health Sciences announced that its board has authorized a share repurchase program on Tuesday, July 25th that authorizes the company to buyback $64.60 million in outstanding shares. This buyback authorization authorizes the company to buy up to 46% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s board believes its stock is undervalued.

COPYRIGHT VIOLATION WARNING: “Insider Selling: USANA Health Sciences, Inc. (USNA) Major Shareholder Sells 43,292 Shares of Stock” was published by American Banking News and is the property of of American Banking News. If you are reading this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright laws. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2017/11/02/insider-selling-usana-health-sciences-inc-usna-major-shareholder-sells-43292-shares-of-stock.html.

A number of research analysts have commented on USNA shares. BidaskClub lowered USANA Health Sciences from a “hold” rating to a “sell” rating in a research report on Sunday, July 16th. Pivotal Research decreased their price objective on USANA Health Sciences from $75.00 to $70.00 and set a “buy” rating on the stock in a research report on Wednesday, July 26th.

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Renaissance Technologies LLC grew its stake in shares of USANA Health Sciences by 10.6% during the second quarter. Renaissance Technologies LLC now owns 1,948,266 shares of the company’s stock worth $124,884,000 after buying an additional 186,600 shares during the last quarter. FMR LLC grew its stake in shares of USANA Health Sciences by 3.9% during the second quarter. FMR LLC now owns 1,598,143 shares of the company’s stock worth $102,441,000 after buying an additional 60,033 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of USANA Health Sciences by 2.6% during the second quarter. Vanguard Group Inc. now owns 979,726 shares of the company’s stock worth $62,801,000 after buying an additional 25,136 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of USANA Health Sciences by 2.3% during the second quarter. Dimensional Fund Advisors LP now owns 710,918 shares of the company’s stock worth $45,570,000 after buying an additional 15,748 shares during the last quarter. Finally, Schroder Investment Management Group grew its stake in shares of USANA Health Sciences by 9.0% during the second quarter. Schroder Investment Management Group now owns 572,186 shares of the company’s stock worth $36,734,000 after buying an additional 47,448 shares during the last quarter. 44.62% of the stock is currently owned by hedge funds and other institutional investors.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.